GranuFlo Lawsuit Filed Against Fresenius for 2008 Death at Dialysis Clinic

May 24, 2014
by The Atkins & Markoff Team

GranuFlo Lawsuit Filed Against Fresenius for 2008 Death at Dialysis Clinic

A Florida woman has filed a lawsuit against the manufacturer of the dialysis product GranuFlo, claiming that the dry acid concentrate administered to her husband by a dialysis clinic in 2008 resulted in his death. Gloria Smith filed the wrongful death lawsuit on October 4, 2012, in federal court, alleging that Fresenius USA Inc. was aware of the risks of deadly cardiac arrest linked to its GranuFlo dialysis treatment when it first introduced the drug in 2003. Unfortunately, Smith alleges, Fresenius waited years before acknowledging the issue with its dialysis product, putting thousands of patients – including husband Leonard Smith – at risk of serious cardiac problems and death. As further attention is brought to the side effect risks associated with Fresenius’ GranuFlo dialysis product, GranuFlo attorneys across the country are investigating personal injury and wrongful death claims filed on behalf of affected patients and their families. If you believe you suffered a side effect or lost a loved one because of GranuFlo treatment, contact our GranuFlo lawyers at AMA Law for legal help.


In her lawsuit, Gloria Smith alleges that her husband, Leonard Smith, died from exposure to Fresenius’ dialysate, GranuFlo/NaturaLyte, while at one of the drug firm’s clinics in Florida. Fresenius operates about one-third of all dialysis centers in the United States, and is also a leading supplier of dialysis products (like GranuFlo) to non-Fresenius clinics in the U.S. and Europe. Dialysate is the fluid used during dialysis treatment that helps draw fluids and toxins out of the bloodstream in patients whose kidneys aren’t functioning properly. According to her complaint, Smith says that her husband suddenly stopped breathing while he was still hooked up to the dialyzer delivering the potentially dangerous dialysis product. Smith additionally states that “top executives” at Fresenius knew or should have known as early as 2003 that its GranuFlo and NaturaLyte products were dangerous.


Since information about life-threatening GranuFlo side effect risks first emerged, Fresenius has been dogged by wrongful death lawsuits filed by individuals who lost loved ones to fatal side effects occurring during or after GranuFlo dialysis treatment. Many of these complaints allege that Fresenius knew or should have known about the dangers associated with its dialysis product, and failed to warn consumers and medical professionals. According to an internal memo issued by Fresenius in November 2011, as many as 941 GranuFlo patients suffered sudden cardiac death the year prior, do to improper administration of the drug. If you received GranuFlo treatment during dialysis and you have since experienced a serious side effect, contact our GranuFlo lawyers at AMA Law today. If you lost a family member to a potential GranuFlo side effect, like cardiac arrest, our experienced GranuFlo attorneys can help you seek fair and timely reimbursement, and can work to hold Fresenius liable for your losses.